Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Hepatitis E Virus Vaccines
Research from W.J. Huang and co-researchers provides new data on hepatitis E virus vaccines
March 25th, 2009
New investigation results, 'Immunogenicity and protective efficacy in rhesus monkeys of a recombinant ORF2 protein from hepatitis E virus genotype 4,' are detailed in a study published in Archives of Virology. According to recent research published in the journal Archives of Virology, "Several antigens derived from hepatitis E virus (HEV) genotype 1 strains have shown immunogenicity and efficacy against hepatitis E in primates and humans. However, the protective effect of a vaccine derived from HEV genotype 4 has not been studied." "This study aimed to evaluate the immunogenicity and protective efficacy of the T1-ORF2 (56 kDa) capsid protein derived from...
Source: Vaccine Weekly (2009-03-25)
|
